欧洲放射肿瘤学市场预测至 2031 年 - 区域分析 - 按类型和应用
市场调查报告书
商品编码
1637689

欧洲放射肿瘤学市场预测至 2031 年 - 区域分析 - 按类型和应用

Europe Radiation Oncology Market Forecast to 2031 - Regional Analysis - by Types and Application

出版日期: | 出版商: The Insight Partners | 英文 87 Pages | 订单完成后即时交付

价格

2023年欧洲放射肿瘤市值为33.1721亿美元,预计2031年将达到87.2307亿美元;预计2023年至2031年复合年增长率为12.8%。

支持放射肿瘤学发展的措施推动欧洲放射肿瘤学市场

各国政府和组织正在引入利用放射疗法快速有效治疗癌症的使命和计划。 2023年9月,国际原子能总署(IAEA)宣布了「希望之光」旗舰癌症倡议,旨在发展放射治疗基础设施。在美国、德国、英国、法国等已开发国家,几乎所有患者都能接受放射治疗。在中等收入国家,60% 的患者群体和低收入国家十分之一的患者能够接受放射治疗。 「人人享有希望之光癌症照护」重点关注全世界放射治疗服务的发展。自该倡议启动以来,各国都收到了放射治疗设备以及操作设备以进行及时诊断和治疗所需的培训。五大洲都参与了该倡议,并为该倡议捐款 4,550 万美元(4,200 万欧元),私营部门投资了 768,902 美元(710,000 欧元)提供支持。此外,医科达等製造商与国际原子能机构签署了合作伙伴关係,透过在世界各地提供放射治疗设备来改善癌症治疗。此外,原子能机构开始培训不同领域的医疗保健专业人员,其中包括14名放射肿瘤学家、13名医学物理学家、4名核子医学技术专家、7名核子医学医师、7名放射性药剂师、16名放射治疗技术专家、7名肿瘤护理师、4名医学影像技术专家和7名放射科医师。因此,放射治疗措施的激增预计将提高低收入国家的渗透率,加上训练有素的专业人员和放射治疗基础设施的发展正在推动未来几年放射肿瘤学市场的成长。

欧洲放射肿瘤学市场概况

德国拥有先进的医疗基础设施,可以使用支援放射治疗程序实施的尖端技术。该国也以其对创新和研究的高度重视而闻名。在德国营运的综合癌症中心提供多学科治疗计划,包括放射治疗、手术、化疗和其他医疗程序。 2020 年,瓦里安宣布位于海德堡的德国癌症研究中心 (DKFZ) 订购了自适应智慧解决方案,这是该国首个 Ethos 疗法。这种由人工智慧驱动的全方位解决方案旨在提高放射治疗的疗效、适应性和能力。

欧洲放射肿瘤学市场收入及 2031 年预测(百万美元)

欧洲放射肿瘤学市场细分

欧洲放射肿瘤学市场按类型、应用和国家分类。

根据类型,欧洲放射肿瘤学市场分为体外放射治疗和内照射放射治疗。 2023 年,体外放射治疗领域将占据更大的市场份额。

从应用来看,欧洲放射肿瘤市场分为乳癌、摄护腺癌、肺癌、头颈癌、子宫颈癌等。 2023 年,乳癌细分市场占据最大的市场份额。

依国家/地区划分,欧洲放射肿瘤市场分为德国、英国、法国、西班牙、义大利和欧洲其他地区。 2023 年,德国在欧洲放射肿瘤市场份额中占据主导地位。

Varian Medical Systems Inc、Elekta AB、Accuray Incorporated、IBA Worldwide (Ion Beam Applications SA)、Becton Dickinson and Co、Nordion、Mevion Medical Systems、NTP RADIOISOTOPES、Mallinckrodt Plc 和 Curium 是欧洲辐射领域的一些领先公司肿瘤学市场。

目录

第 1 章:简介

第 2 章:执行摘要

  • 主要见解

第 3 章:研究方法

  • 二次研究
  • 初步研究
    • 假设表述:
    • 宏观经济因素分析:
    • 显影基数:
    • 数据三角测量:
    • 国家级资料:

第 4 章:欧洲放射肿瘤学市场 - 主要市场动态

  • 市场驱动因素:
    • 癌症盛行率增加
    • 支持放射肿瘤学发展的倡议
  • 市场限制
    • 放射治疗设备成本高
  • 市场机会
    • 放射肿瘤学策略倡议
  • 未来趋势
    • 放射肿瘤学的技术进步
  • 驱动因素和限制的影响:

第 5 章:放射肿瘤学市场 - 欧洲市场分析

  • 放射肿瘤学市场收入,2021-2031

第 6 章:欧洲放射肿瘤学市场分析 - 按类型

  • 外束放射治疗
  • 内束放射治疗

第 7 章:欧洲放射肿瘤学市场分析 - 按应用

  • 乳癌
  • 摄护腺癌
  • 肺癌
  • 头颈癌
  • 子宫颈癌
  • 其他的

第 8 章:欧洲放射肿瘤学市场 - 国家分析

  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区

第 9 章:放射肿瘤学市场 - 产业格局

  • 概述
  • 放射肿瘤学市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 10 章:公司简介

  • Varian Medical Systems Inc
  • Elekta AB
  • Accuray Incorporated
  • IBA Worldwide (Ion Beam Applications SA)
  • Becton Dickinson and Co
  • Nordion
  • Mevion Medical Systems
  • NTP RADIOISOTOPES
  • Mallinckrodt Plc
  • Curium

第 11 章:附录

Product Code: BMIRE00030997

The Europe radiation oncology market was valued at US$ 3,317.21 million in 2023 and is expected to reach US$ 8,723.07 million by 2031; it is estimated to record a CAGR of 12.8% from 2023 to 2031.

Initiatives to Support Developments in Radiation Oncology Drive Europe Radiation Oncology Market

The governments and organizations are introducing missions and programs for the quick and effective treatment of cancer with the use of radiotherapy. In September 2023, the International Atomic Energy Agency (IAEA) announced the "Rays of Hope"-flagship cancer initiative for the development of radiotherapy infrastructure. In developed countries such as the US, Germany, UK, France, and others nearly all patients have access to radiotherapy. In middle-income countries 60% of the patient population and 1 in 10 patients in low-income countries have access to radiotherapy. The "Rays of Hope Cancer Care for All" focuses on the development of radiotherapy services all over the world. Since, launch of the initiative, various countries have received radiotherapy equipment and training required to operate the equipment for timely diagnosis and treatment. All the five continents are involved in the initiative and contributed US$ 45.5 million (Euro 42 million) for the initiative and the private sector invested US$ 768,902 (Euro 710,000) for support. Moreover, manufacturers such as Elekta signed a partnership with IAEA for the improvement of cancer treatment by providing radiotherapy equipment around the world. Additionally, IAEA started training healthcare professionals from different field this includes 14 radiation oncologist, 13 medical physicist, 4 nuclear medicine technologist, 7 nuclear medicine physician, 7 radiopharmacist, 16 radiation therapy technologist, 7 oncology nurses, 4 medical imaging technologist, and 7 radiologists. Therefore, surging initiatives for radiotherapy is expected to increase the penetration in low-income countries along with trained professionals and development in radiotherapy infrastructure is driving the growth of radiation oncology market in coming years.

Europe Radiation Oncology Market Overview

Germany has an advanced healthcare infrastructure with access to cutting-edge technologies that support the implementation of radiotherapy procedures. The country is also renowned for its strong emphasis on innovation and research. Comprehensive cancer centers operating in Germany provide multidisciplinary treatment plans incorporating radiation therapy, surgery, chemotherapy, and other medical procedures. In 2020, Varian announced that the German Cancer Research Center (DKFZ) in Heidelberg ordered an Adaptive Intelligence solution, the first Ethos therapy in the country. This AI-powered, all-encompassing solution aims to improve the efficacy, adaptability, and capacity of radiotherapy.

Europe Radiation Oncology Market Revenue and Forecast to 2031 (US$ Million)

Europe Radiation Oncology Market Segmentation

The Europe radiation oncology market is categorized into types, application, and country.

Based on type, the Europe radiation oncology market is bifurcated into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment held a larger market share in 2023.

In terms of application, the Europe radiation oncology market is categorized into breast cancer, prostate cancer, lung cancer, head and neck cancer, cervical cancer, and others. The breast cancer segment held the largest market share in 2023.

By country, the Europe radiation oncology market is segmented into Germany, the UK, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe radiation oncology market share in 2023.

Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Nordion, Mevion Medical Systems, NTP RADIOISOTOPES, Mallinckrodt Plc, and Curium are some of the leading companies operating in the Europe radiation oncology market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Radiation Oncology Market - Key Market Dynamics

  • 4.1 Market Drivers:
    • 4.1.1 Increasing Prevalence of Cancer
    • 4.1.2 Initiatives to Support Developments in Radiation Oncology
  • 4.2 Market Restraints
    • 4.2.1 High Cost of Radiotherapy Equipment
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives in Radiation Oncology
  • 4.4 Future Trends
    • 4.4.1 Technological Advancement in Radiation Oncology
  • 4.5 Impact of Drivers and Restraints:

5. Radiation Oncology Market - Europe Market Analysis

  • 5.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031

6. Europe Radiation Oncology Market Analysis - by Types

  • 6.1 External Beam Radiation Therapy
    • 6.1.1 Overview
    • 6.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.2 Internal Beam Radiation Therapy
    • 6.2.1 Overview
    • 6.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

7. Europe Radiation Oncology Market Analysis - by Application

  • 7.1 Breast Cancer
    • 7.1.1 Overview
    • 7.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Prostate Cancer
    • 7.2.1 Overview
    • 7.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Lung Cancer
    • 7.3.1 Overview
    • 7.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Head and Neck Cancer
    • 7.4.1 Overview
    • 7.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Cervical Cancer
    • 7.5.1 Overview
    • 7.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Radiation Oncology Market - Country Analysis

  • 8.1 Europe
    • 8.1.1 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
      • 8.1.1.1 Germany: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.1.1 Germany: Radiation Oncology Market Breakdown, by Types
        • 8.1.1.1.2 Germany: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 8.1.1.1.3 Germany: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 8.1.1.1.4 Germany: Radiation Oncology Market Breakdown, by Application
      • 8.1.1.2 United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.2.1 United Kingdom: Radiation Oncology Market Breakdown, by Types
        • 8.1.1.2.2 United Kingdom: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 8.1.1.2.3 United Kingdom: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 8.1.1.2.4 United Kingdom: Radiation Oncology Market Breakdown, by Application
      • 8.1.1.3 France: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.3.1 France: Radiation Oncology Market Breakdown, by Types
        • 8.1.1.3.2 France: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 8.1.1.3.3 France: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 8.1.1.3.4 France: Radiation Oncology Market Breakdown, by Application
      • 8.1.1.4 Spain: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.4.1 Spain: Radiation Oncology Market Breakdown, by Types
        • 8.1.1.4.2 Spain: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 8.1.1.4.3 Spain: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 8.1.1.4.4 Spain: Radiation Oncology Market Breakdown, by Application
      • 8.1.1.5 Italy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.5.1 Italy: Radiation Oncology Market Breakdown, by Types
        • 8.1.1.5.2 Italy: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 8.1.1.5.3 Italy: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 8.1.1.5.4 Italy: Radiation Oncology Market Breakdown, by Application
      • 8.1.1.6 Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.6.1 Rest of Europe: Radiation Oncology Market Breakdown, by Types
        • 8.1.1.6.2 Rest of Europe: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 8.1.1.6.3 Rest of Europe: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 8.1.1.6.4 Rest of Europe: Radiation Oncology Market Breakdown, by Application

9. Radiation Oncology Market - Industry Landscape

  • 9.1 Overview
  • 9.2 Growth Strategies in Radiation Oncology Market
  • 9.3 Organic Growth Strategies
    • 9.3.1 Overview
  • 9.4 Inorganic Growth Strategies
    • 9.4.1 Overview

10. Company Profiles

  • 10.1 Varian Medical Systems Inc
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview (Siemens Healthineers AG)
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Elekta AB
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Accuray Incorporated
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 IBA Worldwide (Ion Beam Applications SA)
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Becton Dickinson and Co
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Nordion
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 Mevion Medical Systems
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 NTP RADIOISOTOPES
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 Mallinckrodt Plc
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments
  • 10.10 Curium
    • 10.10.1 Key Facts
    • 10.10.2 Business Description
    • 10.10.3 Products and Services
    • 10.10.4 Financial Overview
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Radiation Oncology Market Segmentation
  • Table 2. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 3. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 4. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 5. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 6. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 7. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 8. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 9. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 10. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 11. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 12. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 13. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 14. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 15. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 16. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 17. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 18. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 19. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 20. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 21. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 22. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 23. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 24. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 25. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 26. Recent Organic Growth Strategies in Radiation Oncology Market
  • Table 27. Recent Inorganic Growth Strategies in the Radiation Oncology Market
  • Table 28. Glossary of Terms, Radiation Oncology Market

List Of Figures

  • Figure 1. Europe Radiation Oncology Market Segmentation, by Country
  • Figure 2. Radiation Oncology Market - Key Market Dynamics
  • Figure 3. Statistics at Glance, Global, 2022
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Radiation Oncology Market Revenue (US$ Million), 2021-2031
  • Figure 6. Radiation Oncology Market Share (%) - by Types (2023 and 2031)
  • Figure 7. External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Radiation Oncology Market Share (%) - by Application (2023 and 2031)
  • Figure 10. Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Europe Radiation Oncology Market, by Key Countries - Revenue (2023) (US$ Million)
  • Figure 17. Europe: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 18. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 19. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 20. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 21. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 22. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 23. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 24. Growth Strategies in Radiation Oncology Market